Patients News | pharmaphorum

News

Shionogi takes Akili’s ADHD digital therapy to Japan

Digital health company Akili is on the brink of its first major expansion beyond the US, partnering with Shionogi to file a localised version of its attention deficit hype

News

No smartwatch or smart ring can measure blood glucose without a blood sample yet

FDA warns over smartwatches, rings for blood glucose testing

The US FDA has issued a warning against the use of smartwatches or smart ring devices that claim to be able to measure blood glucose levels.

News

Mobile ADHD awareness game launches in Germany

Attention-deficit hyperactivity disorder (ADHD) in adults is not well understood and highly underdiagnosed, but the developers of a mobile game designed to raise awareness

News

Study finds abortion pills by telehealth safe and effective

As all eyes are on a landmark Supreme Court hearing on how patients in the US can access abortion pill mifepristone next month, a study has found that it is safe and effec

News

AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS

Around 1,000 people with Parkinson’s disease will be able to access treatment with AbbVie’s Produodopa, the first therapy that can be delivered by a 24-hour subcutaneous i

News

Study backs safety of Gilead CAR-T as outpatient therapy

CAR-T therapies can achieve remarkable efficacy in the treatment of haematological cancers, but the risk of side effects means that the cell infusions are almost always ad

Shionogi takes Akili’s ADHD digital therapy to Japan

FDA warns over smartwatches, rings for blood glucose testing

Mobile ADHD awareness game launches in Germany

Study finds abortion pills by telehealth safe and effective

AbbVie’s 24-hour Parkinson’s therapy to roll out on NHS

Study backs safety of Gilead CAR-T as outpatient therapy

Boehringer transfers schizophrenia DTx selling rights to Cli...

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks